Status:
COMPLETED
Human Microbiota and Liver Transplant
Lead Sponsor:
Hospital Vall d'Hebron
Conditions:
Intestinal Microbiota
Complication of Transplanted Liver
Eligibility:
All Genders
18-68 years
Brief Summary
The microbiota represents the collections of microbial communities that colonize a host. In health, the microbiota protects against pathogens and maturation of the immune system. In return, the immune...
Eligibility Criteria
Inclusion
- First liver transplant
- Patients aged 18-70 years
- Able to consent and agree in participate in the current study for one year
Exclusion
- Multiorgan transplantation and/or liver transplant from cardiac arrest donor and/or with ABO incompatibility.
- Uncontrolled concomitant infections (including HIV seropositivity) and/or diarrhoea, vomiting or active gastric ulcer.
- Fulminant hepatic insufficiency as first indication for liver transplant
- Hemodynamic instability prior to liver transplant.
- Recipient presenting present or previous neoplasia, except for non-metastatic basal of squamous cutaneous carcinoma or localized hepatocarcinoma with diameter \<5cm or \<3known lesions with diameter \<3cm.
- Significant comorbidity
- Breastfeeding or female patients at fertile age without negative pregnancy test and accepting the use of reliable fertility control method
- Any pretransplant antibiotherapy (oral or endovenous) or enrolled in any clinical assay
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02223468
Start Date
January 1 2016
End Date
August 1 2021
Last Update
August 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Recerca Hospital Vall d´Hebron
Barcelona, Spain, 08035